Status:

COMPLETED

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG

Lead Sponsor:

University of Oxford

Conditions:

Tuberculosis

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

This is a phase I study to examine the safety and immunogenicity of MVA85A delivered intradermally into the deltoid region in volunteers who have recieved BCG in the past 20 years.

Detailed Description

This is a phase I study to examine the safety and immunogenicity of MVA85A delivered intradermally into the deltoid region in volunteers who have recieved BCG in the past 20 years 1\. Selection of vo...

Eligibility Criteria

Inclusion

  • Healthy adult aged 18-55 years.
  • Normal medical history and physical examination.
  • Normal urine dipstick, blood count, liver enzymes, and creatinine.

Exclusion

  • Exposure to TB at any point. Previous residence in a TB endemic area.
  • Clinically significant history of skin disorder (eczema, psoriasis, etc.), allergy, immunodeficiency, cardiovascular disease, respiratory disease, endocrine disorder, liver disease, renal disease, gastrointestinal disease, neurological illness, psychiatric disorder, drug or alcohol abuse.
  • Oral or systemic steroid medication or the use of immunosuppressive agents.
  • Positive HIV antibody test, HCV antibody test or positive HBV serology except post-vaccination.
  • Heaf test greater than Grade II
  • Confirmed pregnancy
  • Previous MVA immunisations

Key Trial Info

Start Date :

May 1 2003

Trial Type :

INTERVENTIONAL

End Date :

January 1 2005

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT00427830

Start Date

May 1 2003

End Date

January 1 2005

Last Update

January 29 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital

Oxford, Oxfordshire, United Kingdom, OX3 7LJ